Abstract
Breast cancer during pregnancy is a dramatic event that interrupts one the most joyful aspects of the life of a woman. The diagnostic/therapeutic setting is deeply affected by the presence of a second individual (the fetus) during its intrauterine development. For this reason, the most common decisional pathways need to be modified to minimize collateral effects. Termination of pregnancy is a possible issue that has to be discussed, although currently no evidence is available regarding any benefit in terms of improved survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rugo HS (2003) Management of breast cancer diagnosed during pregnancy. Curr Treat Options Oncol 4:165–173
Clark RM, Chua T (1989) Breast cancer and pregnancy: the ultimate challenge. Clin Oncol (R Coll Radiol) 1:11–18
Bock P, Hadji P, Ramaswamy A et al (2006) Rationale for a diagnostic chain in gestational breast tumor diagnosis. Arch Gynecol Obstet 273:337–345
Ahn BY, Kim HH, Moon WK et al (2003) Pregnancy and lactation associated breast cancer: mammographic and sonographic findings. J Ultrasound Med 22:491–499
Iman Abbas Hosny, Lamia Adel Salah Eldin, Hamed Samir Elghawabi (2011) Radiological evaluation of palpable breast masses during pregnancy and lactation. The Egyptian Journal of Radiology and Nuclear Medicine 42:267–273
Sabate JM, Clotet M, Torrubia S et al (2007) Radiologic evaluation of breast disorders related to pregnancy and lactation. Radio Graphics 27:101–124
Wani M, Dass TA, Naikoo Z et al (2011) Breast cancer in pregnancy. Eur Surg 43:120–125
Sechopoulos I, Suryanarayanan S, Vedantham S et al (2007) Radiation dose to organs and tissues from mammography: Monte Carlo and phantom study. Radiology 246:434–443
Behrman RH, Homer MJ, Yang WT et al (2007) Mammography and fetal dose. Radiology 243:605–606
Talele AC, Slanetz PJ, Edmister WB et al (2003) The lactating breast: MRI findings and literature review. The Breast Journal 9:237–240
Amant F, Deckers S, Van Calsteren K et al (2010) Breast cancer in pregnancy: Recommendations of an international consensus meeting. European Journal of Cancer 46:3158–3168
Sanchez Martinez MC, Ruiz Simon A (2010) Breast cancer during pregnancy. Breast Cancer Res Treat 123:55–58
Ishida T, Yokoe T, Kasumi F et al (1992) Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan. Jpn J Cancer Res 83:1143–1149
Tobon H, Horowitz LF (1993) Breast cancer during pregnancy. Breast Dis 6:127–134
King RM, Welch JS, Martin JK Jr, Coulam CB (1985) Carcinoma of the breast associated with pregnancy. Surg Gynecol Obstet 160:228–232
Fisher CJ, Egan MK, Smith P et al (1997) Histopathology of breast cancer in relation to age. Br J Cancer 75:593–596
Shousha S (2000) Breast carcinoma presenting during or shortly after pregnancy and lactation. Arch Pathol Lab Med 124:1053–1060
Maru D, Middleton LP, Wang S et al (2005) HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger. Cancer 103:900–905
Lebeau A, Deimling D, Kaltz C et al (2001) Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization. J Clin Oncol 19:354–363
Asselin-Labat ML, Vaillant F, Sheridan JM et al (2010) Control of mammary stem cell function by steroid hormone signaling. Nature 465:798–802
Hoover HC Jr (1990) Breast cancer during pregnancy and lactation. Surg Clin North Am 70:1151–1163
Dominici LS, Kuerer HM, Babiera G et al (2010) Wound complications from surgery in pregnancy-associated breast cancer (PABC). Breast Dis 31:1–5
Gentilini O, Cremonesi M, Toesca A et al (2010) Sentinel lymph node biopsy in pregnant patients with breast cancer. Eur J Nucl Med Mol Imaging 56:78–83
Keleher A, Wendt R III, Delpassand E et al (2004) The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 492:55–57
Pacifici GM, Nottoli R (1995) Placental transfer of drugs administered to the mother. Clin Pharmacokinet 28:235–69
Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:284–291
Espié M, Cuvier C (1998) Treating breast cancer during pregnancy. What can be taken safely? Drug Saf 18:135–142
Wiebe VJ, Sipila PEH (1994) Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 16:75–112
Woo JC, Yu T, Hurd TC (2003) Breast cancer in pregnancy: a literature review. Arch Surg 138:91–98
Giacalone PL, Laffargue F, Benos P (1998) Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 86:2266–2272
GarcÃa-Manero M, Royo MP, Espinos J et al (2009) Pregnancy associated breast cancer. Eur J Surg Oncol 35:215–218
Hahn KM, Johnson PH, Gordon N et al (2006) Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219–1226
Peccatori FA, Azim HA Jr, Scarfone G et al (2009) Weekly epirubicin in the treatment of gestational breast cancer. Breast Cancer Res Treat 115:591–594
Lycette JL, Dul CL, Munar M et al (2006) Effect of pregnancy on the pharmacokinetics of Paclitaxel: a case report. Clin Breast Cancer 7:342–344
Mir O, Berveiller P, Goffinet F et al (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 21:425–433
Aviles A, Neri N, Nambo MJ (2005) Long term evaluation of cardiac function in children who received anthracyclines during pregnancy. Annals of Oncol 17:286–288
Partridge AH, Garber JE (2000) Long term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol 27:712–716
Gwyn K (2005) Children exposed to chemotherapy in utero. J Natl Cancer Inst Monogr 34:69–71
Germann N, Goffinet F, Goldwasser F (2004) Anthracyclines during pregnancy: embryo-foetal outcome in 160 patients. Ann Oncol 15:146–150
Van Calsteren K, Berteloot P, Hanssens M et al (2006) In utero exposure to chemotherapy: effect on cardiac and neurologic outcome. JCO 24:16–17
Boog NN, Ring AE, Crivellari D et al (2010) Breast cancer during pregnancy-a prospective and retrospective European registry (GBG-20/BIG02-03). Proceedings of the European Breast Cancer Conference
Goldhirsch A, Gelber RD (2004) Life with consequences of breast cancer: pregnancy during and after endocrine therapies. The Breast 13:443–445
Amant F, Loibl S, Neven P, Van Calsteren K (2012) Breast cancer in pregnancy. Lancet 379:570–579
RodrÃguez-Pinilla E, MartÃnez-FrÃas ML (1998) Corticosteroids during pregnancy and oral clefts: a case-control study. Teratology 58:2–5
Delle CL, Buck G, Grab D et al (2001) Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group allo-immunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 18:232–236
Pavlidis N, Pentheroudakis G (2008) Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res 178:183–194
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Catalano, F., Scandurra, G., Ravalli, C., Fraggetta, F., Catanuto, G. (2014). Breast Cancer in Pregnancy. In: Mariotti, C. (eds) Oncologic Breast Surgery. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5438-7_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-5438-7_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5437-0
Online ISBN: 978-88-470-5438-7
eBook Packages: MedicineMedicine (R0)